Particle.news

Download on the App Store

Brain Hemoglobin Identified as an Antioxidant Target as Oral Molecule Protects Mice Across Disease Models

The peer‑reviewed study in Signal Transduction and Targeted Therapy remains entirely preclinical.

Illustration representing red blood cells transporting oxygen throughout the bloodstream, with hemoglobin within each cell binding to o2 molecules.
Image
Image

Overview

  • Researchers report that hemoglobin inside astrocyte nucleoli acts as a pseudoperoxidase that breaks down hydrogen peroxide into water.
  • They developed KDS12025, a water‑soluble small molecule that crosses the blood–brain barrier, binds hemoglobin’s heme, and boosts H2O2 decomposition by about 100‑fold without impairing oxygen transport.
  • Oral administration in mice reduced oxidative stress, normalized reactive astrocytes, and preserved neurons, delaying ALS onset and extending survival by more than four weeks.
  • KDS12025 restored motor function in Parkinson’s models, improved memory in Alzheimer’s models, extended median lifespan in aged mice, and reduced inflammation in a rheumatoid arthritis model.
  • The study identifies a harmful loop in which excess peroxide depletes astrocytic hemoglobin; KDS12025’s benefits required astrocytic hemoglobin, and the team plans mechanistic and medicinal chemistry work before human testing.